Lista de obras - Mira Harrison-Woolrych - Dominio Público Uruguay

A New President's Vision for International Pharmacovigilance

scientific article published on 01 February 2020

A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents.

artículo científico publicado en 2009

Alopecia associated with quetiapine

artículo científico publicado en 2007

An Update on ISoP Special Interest Groups (SIGs).

artículo científico publicado en 2017

Breast and pelvic examination in women taking hormone replacement therapy

scientific article published on 01 December 2001

Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand

artículo científico publicado en 2006

Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand

artículo científico publicado en 2012

Clozapine - fatal constipation more common than fatal agranulocytosis

scientific article published on 01 December 2006

Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.

artículo científico publicado en 2008

Ectopic pregnancies following emergency levonorgestrel contraception

artículo científico publicado en 2004

Electronic capture of dispensing data by the New Zealand Intensive Medicines Monitoring Programme: a consultation study of community and hospital pharmacists

artículo científico publicado en 2011

Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres

artículo científico publicado en 2012

Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand

artículo científico publicado en 2020

Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study.

artículo científico publicado en 2013

Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort study

scientific article published on July 2010

Fibroid growth in response to high-dose progestogen

artículo científico publicado en 1995

Focusing on risk communication about medicines: why now?

artículo científico publicado en 2012

Hair loss with use of the levonorgestrel intrauterine device

artículo científico publicado en 2007

How to improve communication for the safe use of medicines?: Discussions on social marketing and patient-tailored approaches at the annual meetings of the WHO Programme for International Drug Monitoring

artículo científico publicado en 2012

ISoP Fellowships: Recognising Contributions to the Goals of ISoP

scientific article published on 01 April 2020

Improving access to emergency contraception

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme

artículo científico publicado en 2005

Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women

artículo científico publicado en 2002

Levonorgestrel intrauterine device can be left in place for five years

artículo científico publicado en 1998

Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility

Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases

artículo científico publicado en 2008

Memory impairment associated with varenicline: a case series from the New Zealand Intensive Medicines Monitoring Programme

artículo científico publicado en 2012

Mental health effects of varenicline

artículo científico publicado en 2015

New study supports MHRA advice on combined oral contraceptives

artículo científico publicado en 2015

Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study

artículo científico publicado en 2011

Nose bleeds associated with use of risperidone

artículo científico publicado en 2004

Patient reporting encouraged during monitoring of dapoxetine in New Zealand

artículo científico publicado en 2011

Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.

artículo científico publicado en 2008

Pregnancies associated with etonogestrel implants in the UK: comparison of two 5-year reporting periods

scientific article published on 10 October 2019

Progestogen-only emergency contraception and ectopic pregnancy

artículo científico publicado en 2003

Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand

artículo científico publicado en 2011

QT interval prolongation associated with sibutramine treatment

artículo científico publicado en 2006

Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study

artículo científico publicado en 2007

Sibutramine may be associated with memory impairment

artículo científico publicado en 2004

Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme

artículo científico publicado en 2007

The New Phase of ISoP.

artículo científico publicado en 2017

The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic

artículo científico publicado en 2020

The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global Pharmacovigilance

artículo científico publicado en 2020

The role and strategy of ISoP in global pharmacovigilance

artículo científico publicado en 2018

The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactions

artículo científico publicado en 2006

Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia

artículo científico publicado en 2005

Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?

artículo científico publicado en 2003

Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres

artículo científico publicado en 2011

Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand

artículo científico publicado en 2010

Varenicline and suicide. Safety data from New Zealand

artículo científico publicado en 2009

Varenicline for smoking cessation.

artículo científico publicado en 2012

Who will fund hypothesis testing studies?

artículo científico publicado en 2006

Lista de obras de Mira Harrison-Woolrych

A New President's Vision for International Pharmacovigilance

A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents.

Alopecia associated with quetiapine

An Update on ISoP Special Interest Groups (SIGs).

Breast and pelvic examination in women taking hormone replacement therapy

Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand

Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand

Clozapine - fatal constipation more common than fatal agranulocytosis

Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.

Ectopic pregnancies following emergency levonorgestrel contraception

Electronic capture of dispensing data by the New Zealand Intensive Medicines Monitoring Programme: a consultation study of community and hospital pharmacists

Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres

Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand

Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study.

Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort study

Fibroid growth in response to high-dose progestogen

Focusing on risk communication about medicines: why now?

Hair loss with use of the levonorgestrel intrauterine device

How to improve communication for the safe use of medicines?: Discussions on social marketing and patient-tailored approaches at the annual meetings of the WHO Programme for International Drug Monitoring

ISoP Fellowships: Recognising Contributions to the Goals of ISoP

Improving access to emergency contraception

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme

Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women

Levonorgestrel intrauterine device can be left in place for five years

Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility

Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases

Memory impairment associated with varenicline: a case series from the New Zealand Intensive Medicines Monitoring Programme

Mental health effects of varenicline

New study supports MHRA advice on combined oral contraceptives

Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study

Nose bleeds associated with use of risperidone

Patient reporting encouraged during monitoring of dapoxetine in New Zealand

Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.

Pregnancies associated with etonogestrel implants in the UK: comparison of two 5-year reporting periods

Progestogen-only emergency contraception and ectopic pregnancy

Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand

QT interval prolongation associated with sibutramine treatment

Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study

Sibutramine may be associated with memory impairment

Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme

The New Phase of ISoP.

The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic

The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global Pharmacovigilance

The role and strategy of ISoP in global pharmacovigilance

The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactions

Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia

Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?

Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres

Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand

Varenicline and suicide. Safety data from New Zealand

Varenicline for smoking cessation.

Who will fund hypothesis testing studies?